This vitamin can leave cancer in the body

The doctors shared the results of studies of vitamin C.

The reproduction of cancerous blood stem cells can stop the use of high doses of vitamin C.

To such conclusion scientists from the United States after they carried out experiments with animals. Recall that the concept of treating cancer with high doses of ascorbic acid was actively discussed by the scientific experts in the 1970-ies.

For blood cancer characterized by the absence of the body’s normal production of leukocytes – white blood cells, can protect a person from infections. Studies conducted earlier showed that 10% of patients with acute myeloid leukemia, 30% of patients with myelodysplastic syndrome (preleukemia) and 50% of patients with chronic myelomonocytic leukemia is a genetic mutation that reduces production TET2 enzyme, which helps the stem cells to transform into normal Mature blood cells.

The authors of the new project, scientists from the Cancer Center Laura and Isaac Perlmutter found that when using high doses of vitamin C are triggered physiological mechanisms for activation of the enzyme TET2. This is the process they observed during the experiments on mice.

“This restoration of the gene that encodes the enzyme TET2 – by demethylation of DNA. This process does not work properly in patients with the mutation, ” – said the researchers.

Scientists said that, using the “method of vitamin C”, they managed to stop the progression of the disease in animals with blood cancer. Also, according to them, the use of ascorbic acid significantly increases the efficiency of treatment of blood cancer when combined with chemotherapy drugs from the group of PARP inhibitors.

Specialists intend to test the efficiency of intravenous injection of vitamin C in certain types of blood cancer in humans. They noted that they hope to detect other drugs for chemotherapy, which will be equally effective in combination with vitamin C, which turned out to be drugs, proved during the experiment.

© 2017 – 2019, paradox. All rights reserved.